SLU-PP-332 (250MCG)

SLU‑PP‑332 is a synthetic small-molecule peptide-like compound developed at Saint Louis University School of Medicine. It functions as a potent pan-agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ), with highest affinity for ERRα (EC₅₀ ≈ 98 nM) [1]. In preclinical research, this compound mimics key effects of endurance exercise—such as enhanced energy metabolism, mitochondrial biogenesis, and fat oxidation—while not influencing estrogen receptor pathways.